Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
0.684
-0.026 (-3.66%)
At close: Dec 20, 2024, 4:00 PM
0.680
-0.004 (-0.58%)
After-hours: Dec 20, 2024, 7:45 PM EST
Unicycive Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for UNCY stock have an average target of 5.50, with a low estimate of 3.00 and a high estimate of 9.00. The average target predicts an increase of 704.09% from the current stock price of 0.68.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 22, 2024.
Analyst Ratings
The average analyst rating for UNCY stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Reiterates $3 | Buy | Reiterates | $3 | +338.60% | Nov 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2.5 → $4 | Strong Buy | Maintains | $2.5 → $4 | +484.80% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $2.5 | Strong Buy | Reiterates | $2.5 | +265.50% | Nov 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $2.5 | Strong Buy | Reiterates | $2.5 | +265.50% | Oct 9, 2024 |
| Benchmark | Benchmark | Buy Reiterates $3 | Buy | Reiterates | $3 | +338.60% | Sep 6, 2024 |
Financial Forecast
Revenue This Year
n/a
from 675.00K
Revenue Next Year
33.15M
EPS This Year
-0.56
from -1.28
EPS Next Year
-0.21
from -0.56
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | 123.4M | 636.2M | |||
| Avg | n/a | 33.1M | 327.7M | |||
| Low | n/a | 2.2M | 21.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | 1,819.5% | |||
| Avg | - | - | 888.7% | |||
| Low | - | - | -34.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.39 | 0.55 | 1.97 | |||
| Avg | -0.56 | -0.21 | 1.02 | |||
| Low | -0.87 | -0.50 | -0.22 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.